Table of Contents Author Guidelines Submit a Manuscript
Volume 2, Pages 1676-1684
Research Article

Nebivolol Ameliorates Nitric Oxide–Deficient Hypertension

Departamento de Fisiología, Facultad de Medicina, 30100 Murcia, Spain

Received 22 February 2002; Revised 29 April 2002; Accepted 1 May 2002

Copyright © 2002 L.A. Fortepiani et al.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • Begona Cenador, Jose M. Lopez-Novoa, Stefano Evangelista, Alejandro Esteller, Miguel Arevalo, Ana B. Rodriguez-Pena, Maria J. Pires, Angel Sanchez-Rodriguez, and Aura Colaco, “Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction,” Journal Of Hypertension, vol. 25, no. 12, pp. 2486–2496, 2007. View at Publisher · View at Google Scholar
  • P.E. Nguelefack-Mbuyo, S. Afkir, T. Dimo, A. Legssyer, A. Ziyyat, T.B. Nguelefack, A.B. Dongmo, A.G.B. Azebaze, and A. Kamanyi, “Anti-hypertensive effects of the methanol/methylene chloride stem bark extract of Mammea africana in l-NAME-induced hypertensive rats,” Journal of Ethnopharmacology, vol. 117, no. 3, pp. 446–450, 2008. View at Publisher · View at Google Scholar
  • N. C. Moningka, T. Tsarova, J. M. Sasser, and C. Baylis, “Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade,” Nephrology Dialysis Transplantation, vol. 27, no. 3, pp. 913–920, 2011. View at Publisher · View at Google Scholar
  • Giuseppe Sacco, Stefano Evangelista, Stefano Manzini, Massimo Parlani, and Mario Bigioni, “Combined antihypertensive and cardioprotective effects of nebivolol and hydrochlorothiazide in spontaneous hypertensive rats,” Future Cardiology, vol. 7, no. 6, pp. 757–763, 2011. View at Publisher · View at Google Scholar
  • Ming-Guo Feng, Minolfa C. Prieto, and L. Gabriel Navar, “Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation,” American Journal of Physiology - Renal Physiology, vol. 303, no. 5, pp. F775–F782, 2012. View at Publisher · View at Google Scholar
  • Yan Wang, Stefano Evangelista, Yu Liu, and Ming-Sheng Zhang, “Beneficial effects of nebivolol and hydrochlorothiazide combination in spontaneously hypertensive rats,” Journal of International Medical Research, vol. 41, no. 3, pp. 603–617, 2013. View at Publisher · View at Google Scholar
  • Facundo Martín Bertera, Julieta Sofía Del Mauro, Valeria Lovera, Diego Chiappetta, Ariel Héctor Polizio, Carlos Alberto Taira, and Christian Höcht, “Enantioselective pharmacokinetics and cardiovascular effects of nebivolol in L-NAME hypertensive rats,” Hypertension Research, 2013. View at Publisher · View at Google Scholar
  • Thomas D. Giles, John R. Cockcroft, Bertram Pitt, Abhijeet Jakate, and Harold M. Wright, “Rationale for nebivolol/valsartan combination for hypertension,” Journal of Hypertension, vol. 35, no. 9, pp. 1758–1767, 2017. View at Publisher · View at Google Scholar
  • Danielle Claude Bilanda, Paul Désiré D. Dzeufiet, Léontine Kouakep, Bibi Farouck O. Aboubakar, Léonard Tedong, Pierre Kamtchouing, and Théophile Dimo, “Bidens pilosa Ethylene acetate extract can protect against L-NAME-induced hypertension on rats,” BMC Complementary and Alternative Medicine, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  • El-Sayed M El-Sayed, Abd El-Aziz H Abd El-Aziz, and Mohamed M Amine, “Nebivolol enhances the effect of alendronate against methylprednisolone-induced osteoporosis in rats,” Journal of Biochemical and Molecular Toxicology, pp. e22232, 2018. View at Publisher · View at Google Scholar